Why Vir Biotechnology Stock Is Higher Today
Shares of Vir Biotechnology (NASDAQ: VIR) were 12.6% higher as of 12:47 p.m. EST on Wednesday. The big gain came after Vir and GlaxoSmithKline (NYSE: GSK) announced that they're expanding their collaboration to include the development of therapies targeting influenza and other respiratory viruses. Last year, Vir and GlaxoSmithKline teamed up to develop therapies targeting coronaviruses, including the one that causes COVID-19.